UPDATE: Goldman Sachs Upgrades Amneal Pharmaceuticals (AMRX) to Buy
Tweet Send to a Friend
(Updated - March 8, 2021 4:41 AM EST)
Goldman Sachs analyst Nathan Rich upgraded Amneal Pharmaceuticals (: AMRX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Nathan Rich upgraded Amneal Pharmaceuticals (: AMRX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
